glp 1 receptor drugs How GLP-1 Agonists Evolved from Diabetes to Weight Loss Treatments Glucagon-like peptide-1 receptor: mechanisms and
Description
The GLP-1 group showed markedly lower risks of severe complications, including sepsis, acute kidney injury, shock, and the need for mechanical ventilation

Advances in oral peptide therapeutics

Nature (2017) 546:24853

Obese people in general are more prone to suicidal ideation, making it difficult to attribute any suicidal ideation to drugs unless a study using a direct comparison between obese patients on and off GLP1R agonists is completed.[66][67] Conclusion GLP-1 Drugs work for their intended purpose and will likely represent a revolution in the way obesity is treated as well as obesity rates in the developed world

[DOI] [PubMed] [Google Scholar] 47.Locatelli J.C., Costa J.G., Haynes A., Naylor L.H., Fegan P.G., Yeap B.B., Green D.J
